C. Luna (Buenos Aires, Argentina), A. Hill (Edinburgh, United Kingdom)
Late-breaking abstract: Clinical and radiological characteristics of cytomegalovirus pneumonia in immunocompromised patients
S. Juthong, A. Jirarat (HatYai, Thailand)
|   |
Late-breaking abstract: Relationship of asthma to outcome in influenza A/H1N1 2009 infection: FLU-CIN cohort study
M. Semple, W. S. Lim, P. Myles, J. Enstone, P. Openshaw, R. Read, B. Taylor, J. McMenamin, B. Bannister, K. Nicholson, J. Nguyen-Van-Tam, J. N. V. T. Nguyen-Van-Tam (Liverpool, Nottingham, London, Sheffield, Portsmouth, Glasgow, Leicester, United Kingdom)
| |
Experimental rhinovirus infection in moderate asthma
D. Jackson, M. B. Trujillo-Torralbo, J. Del-Rosario, J. Aniscenko, S. Johnston (London, United Kingdom)
| |
Serum microRNA signatures identified in a genome-wide profiling predict the mortality of patients with sepsis
L. Xie, H. Wang (Beijing, Tianjin, China)
| |
Reduction of oxidative stress in successfully treated patients with community acquired pneumonia (CAP), as measured by redox status of coenzyme Q10 (%CoQ-10)
K. Honda, H. Wada, M. Tamura, S. Takata, T. Koide, M. Nakamura, H. Ishii, D. Kurai, T. Saraya, K. Fujii, S. I. Hagiwara, Y. Yamamoto, H. Goto (Tokyo, Tochigi, Japan)
| |
Nontypeable haemophilus influenzae (NTHi) leads to caspase-1-dependent upregulation of interleukin 1-beta (IL-1β) in respiratory cells and human lung tissue – A role of the "inflammasome" in respiratory tract infections
J. Rotta detto Loria, K. Rohmann, T. Goldmann, J. Rupp, D. Droemann, K. Dalhoff (Luebeck, Borstel, Germany)
| |
Joint use of specific and nonspecific means for prevention of pneumonia in recruits
P. Ogarkov, S. Zhogolev, K. Jogolev (St. Petersburg, Russian Federation)
| |
The use of influenzal (IV) and pneumococcal (PV) vaccine in patients, staff and visitors at a university hospital in two periods
P. Fescina, V. Martin, F. Ramundo, G. Lonegro, I. Palma, C. M. Luna (Buenos Aires, Argentina)
| |
Procalcitonin in pleural fluid: A new tool for the diagnosis of empyema and parapneumonic pleural effusions?
E. Hoguet, C. Andrejak, A. M. Bourgeois, C. Dayen, V. Jounieaux, Y. Douadi (Amiens, Saint Quentin, France)
| |
Hyaluronic acid levels are increased in parapneumonic pleural effusions
T. Zaga, D. Makris, I. Tsilioni, S. Oikonomidi, T. Kyropoulos, A. Damianos, K. Gourgoulianis (Larissa, Athens, Greece)
| |
Compliance with CURB-65 score and the consequences of no implementation
Q. Guo, H. Y. Li, Y. P. Zhou, M. Li, X. K. Chen, H. Liu, H. L. Peng, H. Q. Yu, X. Chen, N. Liu, L. H. Liang, Q. Z. Zhao, M. Jiang (Shenzhen, Guangzhou, China)
| |
Viral vs bacterial community-acquired pneumonia: Radiologic features
A. Robles, A. San Gil, V. Pascual, E. Calbo, E. Viladot, S. Benet, B. Barreiro, E. Cuchi, J. Torres, L. Canales, J. A. De Marcos, J. Perez, J. Garau (Terrassa, Spain)
| |
Metapneumovirus pneumonia in allogeneic stemcell transplant recipients
A. Egli, J. Halter, D. Heim, M. Stern, C. Bucher, H. Hirsch, M. Tamm (Basel, Switzerland)
| |
Non-tuberculous infections in patients with TNF-alpha-antagonist treatment
T. Cagatay, A. Erer, S. Karaosman, G. Okumus, N. Oktay, B. Ozcelik, P. Cagatay, Z. Kilicaslan, Z. Gulbaran (Istanbul, Turkey)
| |
Do prognostic factors help physicians in predicting legionellosis‘ respiratory complications?
S. Seghezzi, M. Di Pasquale, C. Bonino, E. Prina, S. Aliberti, F. Nicoli, A. M. Brambilla, R. Cosentini (Milan, Monza, Italy)
| |
Clinical stability in patients with community- acquired pneumonia (CAP)
T. Pejcic, I. Stankovic, I. Djordjevic, Z. Ciric, T. Radenovic-Petkovic, D. Nastasijevic, M. Radovic (Nis, Republic Of Serbia)
| |
Chlamydia pneumoniae(Cp)-specific IgE is associated with asthma severity
D. Hahn, K. Patel, E. Drizik, W. Webley (Madison, Amherst, United States Of America)
| |
Chlamydia pneumoniae infection in patients with mild asthma
D. Dokic, S. Aziri, E. Trajkovska-Dokic, D. Karkinski (Skopje, Fyrom)
| |